Autopsy report · NCT02041299

Efficacy and Safety of Ferriprox® in Patients With Sickle Cell Disease or Other Anemias

“Difficulties with additional recruitment as pool of potential patients was exhausted, and sufficient information for determination of study outcome measure was already obtained”

The sponsor’s own words in the registry.

Life of this trial

• Registered 3 months before it started.
• Ran for about 5 years 2 months before it stopped.
• 230 participants enrolled.
• Results were posted on the registry 2 years 2 months after it ended.

Vital statistics

Status

Terminated

Phase

Phase 4

Sponsor

ApoPharma

Sponsor type

Industry

Conditions

Iron Overload; Sickle Cell Disease; Other Anemias

Interventions

Deferiprone; Deferoxamine

Participants

230

Sites

33

Countries

Brazil, Canada, Egypt, Saudi Arabia, Tunisia, Turkey (Türkiye), United Kingdom, United States

Trials that died the same way

• Clinical Trials to Assess Safety and Efficacy of DWRX2003 Combination With Remdesivir in Moderate to Severe COVID-19 Patients.
  “Study stopped due to difficulties in patient recruitment” (76% match in meaning)
• Efficacy of EndoClot™ Spraying After Endoscopic Resection of Large Colorectal Polyps
  “insufficient recruitment of study patients” (75% match in meaning)
• Pleural Suction Additional to Thoracostomy Tube for Traumatic Hemothorax
  “It was not possible to achieve adequate recruitment to complete the necessary sample. The rate at which patients are recruited does not allow for continued participation” (75% match in meaning)
• Vitamin D Levels In Patients Who Has Normal to Grade 2 Knee Arthroscopy Changes
  “Lack of patients with recruitment criteria” (75% match in meaning)
• Effect of Rufinamide on Chronic Postthoracotomy Pain Syndrome
  “Poor study patient recruitment” (74% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.